Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v6-FR
Language French French
Date Updated 2021-05-03 2021-05-03
Drug Identification Number 02357488 02357488
Brand name SANDOZ REPAGLINIDE SANDOZ REPAGLINIDE
Common or Proper name SANDOZ REPAGLINIDE SANDOZ REPAGLINIDE
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients REPAGLINIDE REPAGLINIDE
Strength(s) 2MG 2MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100TAB BO CA 100TAB BO CA
ATC code A10BX A10BX
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-03-19 2021-03-19
Estimated end date 2021-04-30 2021-04-30
Actual end date 2021-04-30 2021-04-30
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments